CardioKinetix's Series E Round

CardioKinetix raised a round of funding on September 20, 2011.

CardioKinetix develops a percutaneous treatment for patients with left ventricular dilation after an anterior myocardial infarction (MI). The implantable device, called the PARACHUTE is a partitioning…

Articles about CardioKinetix's Series E Round: